tellurous acid has been researched along with Cancer of Ovary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bindoli, A; Björnstedt, M; Fernandes, AP; Folda, A; Gandin, V; Marzano, C; Rigobello, MP; Rundlöf, AK | 1 |
Bindoli, A; Björnstedt, M; Citta, A; Fernandes, AP; Folda, A; Gandin, V; Marzano, C; Rigobello, MP; Rundlöf, AK; Scutari, G | 1 |
2 other study(ies) available for tellurous acid and Cancer of Ovary
Article | Year |
---|---|
Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift.
Topics: Adenocarcinoma; Auranofin; Cell Death; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Ovarian Neoplasms; Sodium Selenite; Tellurium; Thioredoxin-Disulfide Reductase | 2009 |
Interaction of selenite and tellurite with thiol-dependent redox enzymes: Kinetics and mitochondrial implications.
Topics: Animals; Auranofin; Cell Line, Tumor; Cell Membrane Permeability; Female; Glutathione Reductase; Humans; Kinetics; Membrane Potential, Mitochondrial; Mitochondria, Liver; Ovarian Neoplasms; Oxidation-Reduction; Pyridines; Rats; Sodium Selenite; Substrate Specificity; Sulfhydryl Compounds; Tellurium; Thioredoxin-Disulfide Reductase; Yeasts | 2011 |